Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement
|Articles|August 3, 2011

Emergency Contraception (Evidence Based)

Author(s)Ashraf Fouda, MD
Advertisement

Advertisement
Contraception

Related Content

Advertisement

Jeffrey Jensen, MD, contextualizes contraceptive efficacy in modern trials

ByJoshua Fitch, Senior Editor ,Jeffrey Jensen, MD, MPH
August 4th 2026
Jeffrey Jensen, MD, MPH, welcomes the newly approved Gwyn Lo contraceptive patch as an expanded, low-estrogen option for patients seeking a once-weekly method.

Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo

ByJoshua Fitch, Senior Editor ,Jeffrey Jensen, MD, MPH
August 3rd 2026
FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

ByJoshua Fitch, Senior Editor
July 29th 2026
Contemporary OB/GYN's top stories from the first half of 2026 | Image credit: Stock.adobe.com

Contemporary OB/GYN's top stories from the first half of 2026

ByJoshua Fitch, Senior Editor
July 1st 2026
5 women's health FDA headlines you missed in Q2 2026| Image credit: Contemporary OB/GYN

5 women's health FDA headlines you missed in Q2 2026

ByJoshua Fitch, Senior Editor
June 29th 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

View more
Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

TMP-SMX linked to higher UTI treatment failure in postmenopausal women vs. nitrofurantoin and fosfomycin

2

Jeff Andrews, MD, on raising awareness and identifying candidates for HPV self-collection

3

HCV testing and postpartum treatment gaps persist among pregnant women with opioid use disorder

4

Liz Miracle, PT, on benefits of virtual pelvic floor physical therapy

5

Mark Simon, MD, on maternity care deserts and the clinical toll of longer travel times

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us